7770 Regents Roas
Suite 113-618
San Diego, CA 92122
United States
858 550 1900
https://www.evofem.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 37
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Ms. Saundra Pelletier | Interim Chair, President & CEO | 1.52M | N/A | 1970 |
Ms. Ivy Zhang | CFO & Secretary | 438.85k | N/A | 1979 |
Ms. Amy Raskopf | Senior Vice President of Investor Relations | N/A | N/A | N/A |
Kathy Gallo-Doyle | Vice President of Sales | N/A | N/A | N/A |
Ms. Rachael Hildebrandt P.H.R. | Head of Human Resources | N/A | N/A | N/A |
Ms. Ellen Thomas | Chief of Staff | N/A | N/A | N/A |
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Evofem Biosciences, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.